[{"address1": "420 Stevens Avenue", "address2": "Suite 230", "city": "Solana Beach", "state": "CA", "zip": "92075", "country": "United States", "phone": "858 345 1494", "website": "https://www.evokepharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Matthew J. D'Onofrio MBA", "age": 53, "title": "Co-Founder, CEO & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 779371, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Marilyn R. Carlson D.M.D., M.D., RAC.", "age": 75, "title": "Chief Medical Officer", "yearBorn": 1948, "fiscalYear": 2023, "totalPay": 681239, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark A. Kowieski CPA", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Quesenberry", "title": "Chief Commercial Officer - Gimoti (TM)", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.79, "open": 5.9, "dayLow": 5.64, "dayHigh": 6.0, "regularMarketPreviousClose": 5.79, "regularMarketOpen": 5.9, "regularMarketDayLow": 5.64, "regularMarketDayHigh": 6.0, "beta": 0.385, "forwardPE": 24.333334, "volume": 34094, "regularMarketVolume": 34094, "averageVolume": 429596, "averageVolume10days": 2243370, "averageDailyVolume10Day": 2243370, "bid": 5.63, "ask": 6.1, "bidSize": 100, "askSize": 100, "marketCap": 4784548, "fiftyTwoWeekLow": 3.54, "fiftyTwoWeekHigh": 17.88, "priceToSalesTrailing12Months": 0.6357604, "fiftyDayAverage": 4.96418, "twoHundredDayAverage": 6.145865, "currency": "USD", "enterpriseValue": 113606, "profitMargins": -0.86747, "floatShares": 536357, "sharesOutstanding": 819272, "sharesShort": 25992, "sharesShortPriorMonth": 65617, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0317, "heldPercentInsiders": 0.09273, "heldPercentInstitutions": 0.33372003, "shortRatio": 0.65, "shortPercentOfFloat": 0.032, "bookValue": 3.627, "priceToBook": 1.6101462, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -6528346, "trailingEps": -16.03, "forwardEps": 0.24, "pegRatio": -0.06, "enterpriseToRevenue": 0.015, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "EVOK", "underlyingSymbol": "EVOK", "shortName": "Evoke Pharma, Inc.", "longName": "Evoke Pharma, Inc.", "firstTradeDateEpochUtc": 1380115800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "abcf0009-3a96-3d48-8e1a-293b075f6af2", "gmtOffSetMilliseconds": -18000000, "currentPrice": 5.84, "targetHighPrice": 18.0, "targetLowPrice": 18.0, "targetMeanPrice": 18.0, "targetMedianPrice": 18.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 9177836, "totalCashPerShare": 12.49, "totalDebt": 5000000, "quickRatio": 1.181, "currentRatio": 1.281, "totalRevenue": 7525709, "debtToEquity": 187.62, "revenuePerShare": 10.241, "returnOnAssets": -0.36798, "returnOnEquity": -4.0759697, "freeCashflow": -1849377, "operatingCashflow": -5547714, "revenueGrowth": 1.255, "grossMargins": 0.96971, "operatingMargins": -0.47957, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-07"}]